Hepatorenal syndrome natural history, complications and prognosis

Jump to navigation Jump to search

Hepatorenal syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hepatorenal syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hepatorenal syndrome natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hepatorenal syndrome natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hepatorenal syndrome natural history, complications and prognosis

CDC on Hepatorenal syndrome natural history, complications and prognosis

Hepatorenal syndrome natural history, complications and prognosis in the news

Blogs on Hepatorenal syndrome natural history, complications and prognosis

Directions to Hospitals Treating Hepatorenal syndrome

Risk calculators and risk factors for Hepatorenal syndrome natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Overview

Hepatorenal syndrome progresses from pre-ascitic stage to frank ascites. Multiorgan system failure, infections and chronic renal failure are the most common complication of HPS. Type I HPS carries poorer prognosis compared to type II HPS.

Natural History

Pre-ascites Phase

Systemic vasodilatation causes kidneys to retain sodium and water, thereby overcoming the compensatory renal vasoconstriction. This prevents the drop in glomerular filtration rate and subsequent vasoconstriction of renal arterioles.[1][2]

Ascitic Phase

As the systemic vasodilatation worsens further, the kidney's are unable to compensate and renal arterioles undergo vasoconstriction. As a result, there is sodium and water retention from the renal tubules resulting in ascites. This ascites is responsive to diuretics. Further increase in renal sodium retention causes the ascites to become resistant to treatment with diuretics.[3][4][5]

Once the ascites progresses to a point where it is unresponsive to diuretics, even repeated paracentesis does not prevent progression to hepatorenal syndrome type I or II.[6][7]

Complications

Hepatorenal syndrome complications include:

Prognosis

  • Type I HRS carries a very poor prognosis, usually of less than 50% over one month. Patients with type I hepatorenal syndrome are usually ill, may have low blood pressures, and may require therapy with inotropes, or intravenous drugs to maintain blood pressure.[8]
  • It is typically associated with ascites that is unresponsive to diuretic medications, and also carries a poor, if somewhat longer (median survival ~6 months) outlook,[9] unless the patient undergoes liver transplantation.

References

  1. Sersté T, Lebrec D, Valla D, Moreau R (2008). "Incidence and characteristics of type 2 hepatorenal syndrome in patients with cirrhosis and refractory ascites". Acta Gastroenterol Belg. 71 (1): 9–14. PMID 18396743.
  2. Mathurin S, Jaimet C, Turletti C, Arosio A, González G, Kuzmicz G (2008). "[Renal failure in patients with cirrhosis and ascites: incidence, etiology and predictive factors]". Acta Gastroenterol Latinoam. 38 (2): 116–25. PMID 18697406.
  3. Mathurin S, Jaimet C, Turletti C, Arosio A, González G, Kuzmicz G (2008). "[Renal failure in patients with cirrhosis and ascites: incidence, etiology and predictive factors]". Acta Gastroenterol Latinoam. 38 (2): 116–25. PMID 18697406.
  4. Fabrizi F, Aghemo A, Messa P (2013). "Hepatorenal syndrome and novel advances in its management". Kidney Blood Press Res. 37 (6): 588–601. doi:10.1159/000355739. PMID 24356549.
  5. de Mattos ÁZ, de Mattos AA, Méndez-Sánchez N (2016). "Hepatorenal syndrome: Current concepts related to diagnosis and management". Ann Hepatol. 15 (4): 474–81. PMID 27236146.
  6. Wong F, Leung W, Al Beshir M, Marquez M, Renner EL (2015). "Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation". Liver Transpl. 21 (3): 300–7. doi:10.1002/lt.24049. PMID 25422261.
  7. Heemann U, Füeßl HS, Renders L (2015). "[The hepatorenal syndrome]". Dtsch Med Wochenschr. 140 (20): 1520–3. doi:10.1055/s-0041-105807. PMID 26445256.
  8. Pandey CK, Karna ST, Singh A, Pandey VK, Tandon M, Saluja V (2014). "Hepatorenal syndrome: a decade later". J Assoc Physicians India. 62 (8): 696–702. PMID 25856938.
  9. Blendis L, Wong F. The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome. Clin Med 2003 Mar-Apr;3(2):154-9. PMID 12737373

Template:WH Template:WS